- Previous Close
34.84 - Open
34.78 - Bid 32.36 x --
- Ask 35.76 x --
- Day's Range
33.98 - 34.78 - 52 Week Range
32.80 - 53.70 - Volume
3,740 - Avg. Volume
51,478 - Market Cap (intraday)
10.963B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
27.47 - EPS (TTM)
1.24 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield 0.85 (2.37%)
- Ex-Dividend Date Apr 21, 2023
- 1y Target Est
--
Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and safe working conditions for healthcare professionals in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and preventive injuries prevention, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.
www.arjo.com6,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0HQ8.IL
View MorePerformance Overview: 0HQ8.IL
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0HQ8.IL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0HQ8.IL
View MoreValuation Measures
Market Cap
9.39B
Enterprise Value
13.91B
Trailing P/E
18.61
Forward P/E
13.51
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.82
Price/Book (mrq)
1.11
Enterprise Value/Revenue
1.23
Enterprise Value/EBITDA
6.91
Financial Highlights
Profitability and Income Statement
Profit Margin
3.59%
Return on Assets (ttm)
3.47%
Return on Equity (ttm)
4.94%
Revenue (ttm)
10.79B
Net Income Avi to Common (ttm)
387M
Diluted EPS (ttm)
1.24
Balance Sheet and Cash Flow
Total Cash (mrq)
567M
Total Debt/Equity (mrq)
70.43%
Levered Free Cash Flow (ttm)
2.52B